Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01243333 · ClinicalTrials.gov registry record · NA
Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors
A NA study, sponsored by University of Utah.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT01243333: Clinical Trial NA study, sponsored by University of Utah.
NCT01243333 is a NA study that was terminated before completion, run by University of Utah. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01243333, a NA study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This clinical trial studies multi-tracer positron emission tomography in patients with solid tumors. Diagnostic procedures, such as multi-tracer positron emission tomography, may help measure a patient's response to treatment.
Primary Outcome
The patients underwent baseline and repeat PET/CT imaging (after one to two cycles of treatment) with \[F-18\]fluorodeoxyglucose (FDG) and \[F-18\]fluorothymidine (FLT). The percent change in the SUVmax for FDG was calculated and used to determine the response. Partial response (PR) was defined as 35% or greater reduction in SUVmax, Progressive Disease (PD) was defined as 35% or greater increase in SUVmax, and Stable Disease (SD) was defined as all other changes in SUVmax.
Interventions
- PROCEDURE Positron Emission Tomography
- RADIATION [F-18]fluorodeoxyglucose
- RADIATION [F-18]fluorothymidine
- RADIATION Water O-15
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2011-02-02 |
| Est. Completion | 2016-04-08 |
| Phase | NA |
Why NCT01243333 stopped before completion
NCT01243333 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which Positron Emission Tomography is the first listed.
NCT01243333 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01243333 about?
NCT01243333 is a clinical study titled "Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors". This clinical trial studies multi-tracer positron emission tomography in patients with solid tumors. Diagnostic procedures, such as multi-tracer positron emission tomography, may help measure a patient's response to treatment.
What is the current status of trial NCT01243333?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2011-02-02. Estimated completion is 2016-04-08.
What interventions are being tested in trial NCT01243333?
The interventions under investigation include: Positron Emission Tomography (PROCEDURE), [F-18]fluorodeoxyglucose (RADIATION), [F-18]fluorothymidine (RADIATION), Water O-15 (RADIATION).
Who is sponsoring clinical trial NCT01243333?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01243333's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI